{"changeSha256":"31da8422cce8f551bf75624c4284bb7be2f04a2d4e2d7adadc40e4678bff31ed","changedAt":"2026-11-14","changedFields":[{"after":"FDA-approved as Symlin","before":"U.S. label record","field":"Status"},{"after":"An amylin analogue approved by FDA as Symlin, an add-on for people with type 1 or type 2 diabetes who use mealtime insulin.","before":"An amylin analogue. This profile cites a U.S. label record.","field":"Profile summary"},{"after":"Large randomized, placebo-controlled trials described in the label found modest additional HbA1c reductions. The label carries a boxed warning about severe low blood sugar when used with insulin.","before":"The cited DailyMed label identifies Pramlintide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.","field":"Evidence note"},{"after":"SymlinPen, Symlin","before":"SymlinPen","field":"Related names"},{"after":"dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18, fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e","before":"dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18","field":"Cited source records"},{"after":"U.S. National Library of Medicine [sources: dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18]; U.S. Food and Drug Administration [sources: fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e]","before":"U.S. National Library of Medicine [sources: dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18]","field":"Named organizations"},{"after":"name: dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18; aliases: dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18, fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e; category: dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18; status: dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18, fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e; summary: dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18, fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e; evidenceNote: dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18","before":"name: dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18; aliases: dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18; category: dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18; status: dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18; summary: dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18; evidenceNote: dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18","field":"Claim citations"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/pramlintide/versions/3/","version":3},"id":"profile:pramlintide:v3","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-status-changed","notice":"We added a plain-language reader guide with cited answers, re-checked the Symlin label, and added the Drugs@FDA approval record.","peptideSlugs":["pramlintide"],"previousChangeEvent":{"path":"/corrections/v1/profiles/pramlintide/v2.json","sha256":"96f7d577600e67df1392103c0c41e01cc5fa1a9cd07877c374b10c8e1185c6ed"},"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/pramlintide/versions/2/","version":2},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"dailymed-pramlintide-4aea30ff-eb0d-45c1-b114-3127966328ff-v18","name":"DailyMed · U.S. National Library of Medicine","sourceClass":"A","title":"SYMLINPEN (pramlintide acetate) injection · SPL version 18 · published 2024-08-20","url":"https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=4aea30ff-eb0d-45c1-b114-3127966328ff&version=18","verifiedAt":"2026-07-22"},{"id":"fda-drugs-nda021332-2005-03-16-bb1cb7c1a09e","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA021332 · original submission status AP · 2005-03-16 · dataset 2026-08-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA021332%22&limit=1","verifiedAt":"2026-08-14"}],"subject":{"slug":"pramlintide","type":"profile"}}
